Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY | 17-AAG |
FIMM | Tanespimycin |
CTRPv2 | tanespimycin |
PharmacoGx | 17-AAG |
Database | Identifier |
---|---|
Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
Pubchem: | 6505803 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NOL4 | GDSC1000 | pan-cancer | AAC | -0.25 | 1e-13 |
mRNA | BLVRB | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-13 |
mRNA | ANXA1 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-13 |
mRNA | IER5L | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-13 |
mRNA | OSGIN1 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-13 |
mRNA | MVP | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-13 |
mRNA | KIF5C | GDSC1000 | pan-cancer | AAC | -0.25 | 3e-13 |
mRNA | ELAVL3 | GDSC1000 | pan-cancer | AAC | -0.28 | 3e-13 |
mRNA | FOSL2 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-13 |
mRNA | SRSF12 | GDSC1000 | pan-cancer | AAC | -0.28 | 4e-13 |